Description

MT-1 10mg × 10 vials

An alpha-melanocyte-stimulating hormone analogue studied for pigmentation research, melanocortin receptor activity, eumelanin production, photoprotection-related pathways, and skin response to UV exposure.

Product Overview

Compound: MT-1
Strength: 10 mg per vial
Injection type: Subcutaneous
Frequency: Research protocol dependent

Reconstitution

Amount in vial: 10 mg
BAC water: 2 mL
Amount per unit: 50 mcg per unit

Research Dose

Protocol dependent.

Notes

MT-1 is commonly associated with Melanotan I / afamelanotide-like research compounds. It is studied as an alpha-MSH analogue involved in melanocortin receptor pathways, pigmentation response, eumelanin production, and UV-related skin research.

Unregulated melanotan use has been associated with skin-related risks, including changes in existing moles and newly emerging melanocytic lesions. No standard consumer dosing protocol should be assumed. Use only within appropriate research or professional guidance frameworks.

Disclaimer

This product is intended for research and informational purposes only.